Suitability of a US3-inactivated HSV mutant (L1BR1) as an oncolytic virus for pancreatic cancer therapy.

2007

Suitability of a US3-inactivated HSV mutant (L1BR1) as an oncolytic virus for pancreatic cancer therapy

Keywords:

Correction
Source
Cite
Save
Machine Reading By IdeaReader

39

References

35

Citations